dc.contributor.author |
Timercan, Tatiana |
|
dc.date.accessioned |
2019-04-16T12:17:03Z |
|
dc.date.available |
2019-04-16T12:17:03Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
TIMERCAN, Tatiana. A modern approach to interleukin-6. In: The Moldovan Medical Journal. 2018, vol. 61, no 3, pp. 47-52. ISSN 2537-6373. |
en_US |
dc.identifier.issn |
2537-6373 |
|
dc.identifier.issn |
2537-6381 |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/1216 |
|
dc.identifier.uri |
https://doi.org/10.5281/zenodo.1299041 |
|
dc.identifier.uri |
http://moldmedjournal.md/wp-content/uploads/2019/01/moldmedjournal-2018-61-3-full-issue.pdf |
|
dc.description |
Department of Biochemistry and Clinical Biochemistry, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova |
en_US |
dc.description.abstract |
Background: Interleukin-6 is a multifunctional cytokine with well-defined pro- and anti-inflammatory properties. Binding to the receptor complex
composed of specific interleukin-6-receptor (IL-6R) and transmembrane glycoprotein gp130, it stimulates various signalling cascades. Intracellular
signal transduction involves both STAT-dependent, and STAT-independent mechanisms. IL-6R exists in the soluble and the membrane-bound forms,
thus were described the classical signalling and the trans-signalling pathways. The pro-inflammatory response occurs via trans-signalling, while the antiinflammatory effects are mediated by classical signalling pathway. IL-6 is produced by cardiovascular components. The high levels of IL-6 are identified
in the inflammatory diseases.
Conclusions: IL-6 expresses the well-defined pro- and anti-inflammatory properties. The experimental studies have revealed classic signalling pathway
with regenerative and anti-inflammatory effects (via the membrane-bound IL-6R), and trans-signalling responsible for the pro-inflammatory response
(via the soluble form sIL-6R). The intracellular signal transduction involves the activation of STATs, MAPK, and PI3K cascades. It has been proved that
in the cardiovascular pathologies the serum levels of IL-6 correlate with the disease severity and the degree of myocardial damage, being the indicator of
heart disease and a predictive factor of adverse outcomes. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
The Scientific Medical Association of the Republic of Moldova |
en_US |
dc.relation.ispartof |
The Moldovan Medical Journal |
|
dc.subject |
interleukin-6 |
en_US |
dc.subject |
cytokine |
en_US |
dc.subject |
trans-signalling |
en_US |
dc.subject |
cardiac ischemia |
en_US |
dc.subject.ddc |
UDC: 577.112.6 |
|
dc.subject.mesh |
Interleukin-6 |
en_US |
dc.subject.mesh |
Cytokines |
en_US |
dc.subject.mesh |
Cell Differentiation |
en_US |
dc.subject.mesh |
Cell Proliferation |
en_US |
dc.subject.mesh |
Cell Movement |
en_US |
dc.subject.mesh |
Apoptosis |
en_US |
dc.subject.mesh |
Glycoproteins |
en_US |
dc.title |
A modern approach to interleukin-6 |
en_US |
dc.type |
Article |
en_US |